Sono-Tek Reports Strong Q1 FY27 Results: Net Income Up 53%, Revenue Up 10%, Beats Estimates
SOTK sits 71% above its 52-week low of $3.23 on light trading volume (0.2× avg).
Summary
Sono-Tek reported strong Q1 FY27 financial results, beating analyst estimates with a 10% increase in revenue and a 53% surge in net income, alongside significant gross margin expansion and a healthy cash position.
Key Events · Earnings and Guidance · SOTK
-
Strong Q1 Financial Performance
Net sales increased 10% to $5.66 million, and net income surged 53% to $741,168, beating analyst estimates of $5.5 million revenue and $0.04 EPS.
-
Significant Profitability Growth
Gross profit margin expanded by 500 basis points to 57%, and operating income increased 86% to $897,160, driven by a favorable product mix.
-
Robust Balance Sheet
The company ended the quarter with $16.6 million in cash, cash equivalents, and marketable securities, an increase of $1.8 million from the prior quarter, and no outstanding debt.
-
Market Diversification Success
Strong growth in the Medical (+388%) and Industrial (+345%) markets offset a 90% decline in Alternative Energy/Clean sales, demonstrating successful market adaptation.
Analysis · SOTK · Technology
Sono-Tek delivered a robust first quarter for fiscal year 2027, significantly exceeding analyst expectations for both revenue and EPS. The company demonstrated strong financial health with a 53% increase in net income and a 10% rise in net sales. A notable achievement was the 500 basis point expansion in gross profit margin, driven by a favorable product mix, particularly high-value medical device coating systems. This performance highlights successful diversification, as strong growth in the Medical and Industrial markets effectively offset a substantial decline in Alternative Energy/Clean sales. The company maintains a strong balance sheet with increased cash and no debt, providing a solid foundation for future operations.
At the time of this filing, SOTK was trading at $5.53 on NASDAQ in the Technology sector, with a market capitalization of approximately $86.9M. The 52-week trading range was $3.23 to $6.24. This filing was assessed with positive market sentiment and an importance score of 8 out of 10.